You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
RFID Based Tracking System for Ultra-Low Temperature Sample Repositories
SBC: BIOTILLION LLC Topic: 100DESCRIPTION provided by applicant The specific aim of this Phase IIb Phase II competitive renewal SBIR proposal is to advance the prototype systems we developed under our Phase II grant into commercial production Our product will be used to automatically track samples in laboratory and biobank freezers Most of these samples are stored in vials Between and million such vials are ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Brain-enriched microRNAs detectable in plasma as biomarkers of Alzheimer's Disease
SBC: DIAMIR, LLC Topic: NIASUMMARY One in 10 Americans aged 65 and older have Alzheimer’s disease (AD). Since AD begins with a prolonged, over 10 year-long, asymptomatic stage, a growing number of companies are developing new therapies that aim to intervene early in the progression of AD and related forms of dementia. There is thus a great need for minimally invasive diagnostic tools for primary screening of individuals w ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Colonoscope Force Monitor
SBC: ARTANN LABORATORIES, INC. Topic: NIDDKDESCRIPTION (provided by applicant): Colonoscopy is the preferred method to screen for colorectal cancer, a disease that afflicts 115,000 new patients a year. Several million screening, diagnostic and therapeutic colonoscopies are performed each year in U.S. hospitals and ambulatory surgery centers. However, colonoscopy remains a highly operator dependent activity and no clear definition of skill ...
SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health -
ChNKG2D-Targeted Cellular Cancer Therapy: Phase I Clinical Trial
SBC: CELDARA MEDICAL, LLC Topic: NHLBIDESCRIPTION (provided by applicant): The global burden of cancer doubled between 1975 and 2000. Cancer became the leading cause of death worldwide in 2010, and is projected to double again by 2020 and to triple by 2030. This horrible disease has touched each of us, and despite enormous investments in prevention and treatment, its impact continues to accelerate. Ideally, any cancer therapy should ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
DRIVEN: Accelerating Medical Entrepreneurship in the Northeast
SBC: CELDARA MEDICAL, LLC Topic: 500Project Summary This project describes the formation, launch and operation of the DRIVEN Accelerator Hub, with the express goal of reducing morbidity and mortality by increasing the number of medical entrepreneurs and their level of competency. The Hub is focused on the Northeast and, in collaboration with similar Hubs, will contribute nationwide. It will, in a facile, complete, and accessible way ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Portable Imaging Device for Prostate Cancer Detection
SBC: ARTANN LABORATORIES, INC. Topic: N/ADESCRIPTION (provided by applicant): The long-term goal of the project is to bring to the market a new tool for prostate cancer screening, the Prostate Mechanical Imager (PMI), which provides real time 3-D reconstruction of prostate capturing its geometrical and mechanical characteristics and aids in detecting tissue abnormalities. The current PMI prototype has undergone several progressions of ha ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Rapid Cystic Fibrosis Mutation Screening Test
SBC: Pharmaseq, Inc Topic: N/ADESCRIPTION (provided by applicant): We propose to configure a DNA-based assay to detect mutations in the gene related to cystic fibrosis (CF), encoding the cystic fibrosis transmembrane conductance regulator protein (CFTR). The assay will have an extende
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Improved cleaning technology for reducing risk of transmitting infection in endoscopy.
SBC: ADVANCED BIODEVICES LLC Topic: R7. Project Summary/Abstract: Outbreaks of infection caused by contaminated endoscopes are a serious public health problem that has even resulted in patient deaths. Currently, because of the narrowness of the channels and complexity of the endoscope, there simply is no reliable way of achieving this. The existing cleaning protocols also are highly dependent on operator technique. Accordingly, this ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
SBC: Immunext, Inc. Topic: RImmuNext has identified and developed a putative lead anti VISTA monoclonal antibodymAbthat we aim to bring to the clinic for the treatment of human autoimmune diseaseVISTA is a member of the highly successful negative checkpoint regulatorNCRfamily of drug targetswhose members have demonstrated proven efficacy in inducing long term remissions in human cancersWe contend that antibodies that suppres ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Regulatory Advancement of HXe as a Diagnostic MRI Contrast Agent
SBC: XEMED LLC Topic: NHLBIDESCRIPTION (provided by applicant): New therapies are in development for COPD (endobronchial valves/stents/glue) and asthma (endobronchial thermal ablation). Hyperpolarized xenon-129 (HXe) MRI, a noninvasive method to assess regional lung structure and function, may prove critical in the guidance of these regional treatments. In our prior work we developed an innovative approach to xenon polariza ...
SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health